Judy Holmes
315) 443-2201
Judy Holmes
BioSym Technologies of Des Moines, Iowa, has signed a 10-year, $5 million research agreement with Syracuse University to support Assistant Professor of Chemistry Robert Doyle and his research team in their groundbreaking efforts to discover new ways to treat such diseases as diabetes, ovarian cancer and tuberculosis. Incorporated in 2007, BioSym Technologies produces specialty ingredients for pharmaceuticals and nutraceuticals and is the only known North American manufacturer of vitamin K2 and B12.
"The partnership between BioSym Technologies and Syracuse University gives recognition to, and support for, high-quality academic research that has a significant impact on the real world, and by doing so is an excellent example of the Chancellor's strategy for Scholarship in Action," says SU's Vice President for Research Ben Ware.
Over the past two years, Doyle and his research team have developed a method to attach insulin to vitamin B12 that may someday enable diabetics to swallow insulin in a pill instead of injecting it with a needle. The team has also been successful in attaching vitamin B9 (folic acid) to agents that can identify and kill drug-resistant ovarian cancer cells. The work may someday enable doctors to detect ovarian cancer at earlier stages than currently possible and to treat tumors more effectively with fewer side effects. It is this kind of basic research that prompted the owners of BioSym Technologies to contact Doyle.
"We are a unique biotechnology company that deals in drug delivery systems and in green technologies, such as biodegradable plastics and fermentation for ethanol production," says BioSym co-owner Mark Smolik. "The direction that Robert Doyle is taking in his research is parallel to ours. We are looking forward to a long-term relationship in supporting Rob's work and in developing synergies between his research lab and ours."
The new partnership will enable Doyle to share ideas with BioSym co-owner and primary scientist Daniel DeBrouse, who has been appointed a research professor in SU's Department of Chemistry in The College of Arts and Sciences. DeBrouse has spent more than 10 years developing new ways to deliver drugs and holds several patents. "This is truly a unique partnership," Smolik says. "Both scientists have expertise across multiple disciplines of science. We always believed there wasn't any other scientist who thought like Daniel until we met Rob. Things could not have worked out better."
June 05, 2012 The program, designed in collaboration with the Casting Society of America, was developed for casting students, including key professional components and core courses with fellow Tepper students.
Read more
August 24, 2012 Natalie Teale, a senior Earth sciences and geography major in Syracuse University’s College of Arts and Sciences, spent the summer as part of an immersive research experience in the cloud forest of Costa Rica.
Read more
September 13, 2012 Syracuse University today announced that it has surpassed its goal for the most ambitious fundraising effort in the institution’s history.
Read more
September 10, 2012 Civil engineering professor Cliff Davidson had a breathtaking view of the City of Syracuse from a rooftop garden recently. But it’s the possibilities of that prime location that made the experience memorable.
Read more
September 10, 2012 Trauma, psychiatric medications, family therapy, nutrition and systems reform are a sampling of the topics experts from across the country will discuss at the Children’s Mental Health Summit, September 27-29 in Syracuse.
Read more
